Richard J. Rodgers

Insider Reports History

Identity
Location
Waltham, MA
SEC record
Reporting signature
/s/ Amy Rabourn, by Power of Attorney
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Richard J. Rodgers:

Form 4 holding Director

NOVAVAX INC

Security class
Stock Option (Right to Buy)
Shares / value
28,326
Estimated value
$181,852
Report date
20 Jun 2025
Price
$6.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

NOVAVAX INC

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$30,400
Report date
29 Oct 2025
Price
$8.00
Ownership
Direct
Underlying class
Restricted Stock Units
Underlying amount
Form 4 holding Director

ARDELYX, INC.

Security class
Stock Option (Right to Buy)
Shares / value
54,059
Estimated value
$0
Report date
18 Jun 2025
Price
$2.32
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Opus Genetics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
79,592
Estimated value
Report date
30 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sagimet Biosciences Inc.

Security class
Stock Option (Right to Buy)
Shares / value
23,839
Estimated value
Report date
18 Jul 2023
Price
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount

Insider Reports Filed by Richard J. Rodgers

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .